Target intelligence / Profile preview

Iron replacement therapy mechanism

Molecular classification
Other (describes a physiological process), Transporters (e.g., Divalent metal transporter 1), Enzymes (e.g., ferrireductases), Storage proteins (e.g., Ferritin)
01

Overview

"Iron replacement therapy mechanism" refers broadly to how supplemental elemental iron corrects deficiencies by restoring normal physiological processes dependent on adequate body stores. After administration—either orally or intravenously—iron enters systemic circulation through regulated intestinal absorption mechanisms involving reduction/transport proteins such as DMT1 and ferroportin. Once absorbed, it binds transferrin for delivery throughout the body where it supports critical functions including hemoglobin production for oxygen transport in red blood cells.[3][4] This process does not represent one discrete molecular target but encompasses several coordinated steps essential for effective treatment of conditions like anemia due to insufficient endogenous supplies.[1]

Other names
Iron supplementation mechanismIron absorption pathwayMechanism of action of iron therapy
02

Mechanism of action

Iron supplements provide bioavailable elemental iron that is absorbed primarily in the duodenum and proximal jejunum. The key steps include: Reduction of dietary ferric iron (Fe3+) to ferrous form (Fe2+) by duodenal cytochrome b. Uptake into enterocytes via divalent metal transporter 1 (DMT1). Export from enterocytes into circulation via ferroportin. Binding to transferrin for systemic distribution. Once absorbed, supplemental iron replenishes depleted stores and supports hemoglobin/myoglobin synthesis.

03

Biological functions

Oxygen transportEnergy generationHemoglobin synthesisMyoglobin functionCellular metabolism
04

Disease associations

Anemia (especially iron-deficiency anemia)Other conditions related to iron deficiency or overload
05

Safety considerations

Gastrointestinal side effects (nausea, constipation)Risk of overdose/toxicity leading to organ damage if excess is administeredAllergic reactions with some intravenous preparations
06

Interacting drugs

Ferrous sulfate

4 more in the full profile.

07

Biomarkers

Hemoglobin concentrationSerum ferritinTransferrin saturationSerum iron levels

Beyond the preview

Go deeper on Iron replacement therapy mechanism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron replacement therapy mechanism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call